PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY
申请人:Cannizzaro Carina
公开号:US20090227543A1
公开(公告)日:2009-09-10
The invention is related to phosphonate substituted compounds having immuno-modulatory activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
3-Beta-D-Ribofuranosylthiazolo[
4,5-D]
Pyridimine Nucleosides and Uses Thereof
申请人:Averett Devron R.
公开号:US20080070852A1
公开(公告)日:2008-03-20
The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds.
METHODS FOR THE PREPARATION OF IMIDAZOLE-CONTAINING COMPOUNDS
申请人:Valiante Nicholas M.
公开号:US20100010217A1
公开(公告)日:2010-01-14
The present invention generally relates to methods for the preparation of compounds that contain imidazole moieties. In some embodiments, the methods include the reaction of a diamine with a dichloroimmonium compound to produce the imidazole moiety. In some embodiments, the methods are employed to prepare compounds having the Formulas II, II or III below: I II III wherein the constituent variables are as described herein.
本发明通常涉及制备含咪唑基团的化合物的方法。在某些实施例中,该方法包括将二胺与二氯咪唑化合物反应以产生咪唑基团。在某些实施例中,该方法用于制备具有以下公式II,II或III的化合物:I II III,其中组分变量如本文所述。
3-B-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF
申请人:Averet Devron R.
公开号:US20080255063A1
公开(公告)日:2008-10-16
The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds.
The invention proyides novel compositions comprising imidazoquinoxaline compounds of formula (I) and analogs thereof. Also provided are methods of administering the compositions in an effective amount to enhance the immune response of a subject. Further provided are novel compositions and methods of administering the compositions in combination with (an) other agent (s).